Cardinal Health plans to spin-off its clinical and medical products businesses as a separate public company that will be led by current vice chairman David L. Schlotterbeck. The spin-off is expected to be completed by mid-2009. This plan is an effort to enhance management focus and strategic vision, as well as better align management and employee incentives with performance and growth objectives, according to the company. Chairman and chief executive officer, R. Kerry Clark, will continue to...